Cashu
Adapting to Market Volatility: Harrow's Strategic Focus in Economic Uncertainty
23 days ago
Stocks
Health Care
hrow
Harrow
NASDAQ: HROW
-1.06 (-2.27%)
45.71
USD
At close at Dec 05, 21:39 UTC
Overview
Loading chart...
Key Stats
Market Cap
1.69B
Dividend Yield
0.00%
P/E Ratio
-339.38
EPS
-0.49
Revenue
199.61M
Avg. Volume
542.60K
About
What does HROW do?
Harrow, headquartered in Nashville, Tennessee, develops and sells innovative ophthalmic medications and operates ImprimisRx, employing 315 staff since its IPO on February 8, 2013. The company markets various prescription products, including VIGAMOX and IHEEZO.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.